Zobrazeno 1 - 10
of 45
pro vyhledávání: '"B. Gronlund"'
Autor:
Estrid Høgdall, Svend Aage Engelholm, Claus Høgdall, B Gronlund, Ib Jarle Christensen, Bent Nørgaard-Pedersen, Julia S. Johansen
Publikováno v:
The International Journal of Biological Markers. 21:141-148
Objective To examine if the determination of the levels of serological tumor markers at time of relapse had any predictive value for chemoresistance in the second-line treatment of ovarian cancer patients. Methods From a registry of consecutive singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3c949843851eab1c0b79708b24ce885
https://doi.org/10.5301/jbm.2008.5055
https://doi.org/10.5301/jbm.2008.5055
Autor:
H Dehn, S.A. Engelholm, B Gronlund, Claus Høgdall, Estrid Høgdall, Morten Jørgensen, Bent Nørgaard-Pedersen
Publikováno v:
International Journal of Gynecological Cancer. 15:836-843
The aim was to examine the value of the pretherapeutic serum cancer-associated serum antigen (CASA) level as a prognostic factor for survival in patients with recurrent epithelial ovarian carcinoma. Serum levels of CASA and cancer antigen (CA)125 wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de14395718c23754de702838dde7703f
https://doi.org/10.1111/j.1525-1438.2005.00145.x
https://doi.org/10.1111/j.1525-1438.2005.00145.x
Autor:
B Gronlund, Jørgen Hilden, Heine H. Hansen, Claus Høgdall, Svend Aage Engelholm, Estrid Høgdall
Publikováno v:
Journal of Clinical Oncology. 22:4051-4058
Purpose The aim of the study was to compare the prognostic value of a response by the Gynecologic Cancer Intergroup (GCIG) Cancer Antigen (CA) -125 response criteria and the Response Evaluation Criteria in Solid Tumors (RECIST) on survival in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4843faedba38217303db9b442c4fe044
https://doi.org/10.1200/jco.2004.10.028
https://doi.org/10.1200/jco.2004.10.028
Publikováno v:
Gynecologic Oncology. 94:409-415
Objective. Recurrent ovarian carcinoma is considered an incurable disease and second-line chemotherapy is administered for extension of survival and palliation. The impact of continued antineoplastic treatment in patients with stable disease without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23334a5b47151e0c7aacbe7605421bc3
https://doi.org/10.1016/j.ygyno.2004.05.005
https://doi.org/10.1016/j.ygyno.2004.05.005
Publikováno v:
British Journal of Cancer
Recent studies indicate that cancer antigen 125 (CA125) response criteria tend to overestimate a tumour reduction measured by standard WHO response criteria in recurrent epithelial ovarian carcinoma. The aim of the study was to validate the recently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aaf5adc5157ed0ea5627a8870592e3e
https://doi.org/10.1038/sj.bjc.6601501
https://doi.org/10.1038/sj.bjc.6601501
Publikováno v:
Gynecologic Oncology. 83:128-134
Objective. The purpose of the study was to evaluate the treatment results and toxicity of a retreatment regimen of paclitaxel and carboplatin in patients with ovarian cancer relapse. Methods. A retrospective analysis of 241 consecutive patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eda73483654a1516b5665e4e50da14b1
https://doi.org/10.1006/gyno.2001.6364
https://doi.org/10.1006/gyno.2001.6364
Publikováno v:
Biosensors and Bioelectronics. 7:683-687
A new prototype direct reading glucose electrode working with glucose oxidase and hydrogen peroxide was preliminary tested clinically during insulin-induced hypoglycemia in eight healthy subjects, and during hyperglycemia in five dysregulated diabeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a634551dc6215b4bef78766976e9c1
https://doi.org/10.1016/0956-5663(92)85049-g
https://doi.org/10.1016/0956-5663(92)85049-g
Autor:
B. Gronlund, E.V.S. Høgdall, I.J. Christensen, J.S. Johansen, B. Nørgaard-Pedersen, S.A. Engelholm, C. Høgdall
Publikováno v:
The International journal of biological markers. 21(3)
Objective To examine if the determination of the levels of serological tumor markers at time of relapse had any predictive value for chemoresistance in the second-line treatment of ovarian cancer patients. Methods From a registry of consecutive singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df6c5c13d1807c855a99f5b55dc8448a
https://pubmed.ncbi.nlm.nih.gov/17013795
https://pubmed.ncbi.nlm.nih.gov/17013795
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 31(1)
Aim The objective was to analyse the impact of secondary cytoreductive surgery in patients with recurrent ovarian carcinoma. Methods Retrospective review of 572 consecutive patients with primary ovarian carcinoma. Thirty-eight patients with intraabdo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94922603f729c9b4131b1df8fffc1937
https://pubmed.ncbi.nlm.nih.gov/15642428
https://pubmed.ncbi.nlm.nih.gov/15642428
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 8(1)
The effect of insulin-induced hypoglycaemia on the absorption of iodine-125 labelled unmodified insulin (10 U) from thigh after subcutaneous or intramuscular injection was studied in eight immobilized, supine, normal subjects. Ultrasonic determinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::725abede8b568adaa45b73870bcf7679
https://pubmed.ncbi.nlm.nih.gov/1826237
https://pubmed.ncbi.nlm.nih.gov/1826237